Dr. Mark Flory describes his work with the Proteograph Product Suite, his collaboration with Seer, and the studies that unbiased, deep proteomics are unlocking for his lab.
An overview of the Proteograph Product Suite, Seer’s proprietary engineered nanoparticle technology and the applications enabled by this solution.
Shadi Ferdosi, Ph.D. reviews the performance of the Proteograph Product Suite in combination with the Bruker timsTOF mass spectrometry platform using both DDA and DIA analysis.
From AACR 2021, this poster demonstrates that measurements at the peptide level for the plasma proteome enable quantification of differential isoform abundance patterns using the Proteograph Product Suite.
John Blume, Ph.D., discusses how the Proteograph Product Suite can be used to identify novel and known candidate biomarkers in Alzheimers and Mild Cognitive Impairment (MCI)
Mark Flory, Ph.D. from Oregon Health Sciences University, Knight Cancer Institute, CEDAR shares a comparison of traditional deep proteomics by protein fractionation with the Seer Proteograph Product Suite